EVOGENE LTD's ticker is EVGN and the CUSIP is M4119S104. A total of 24 filers reported holding EVOGENE LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $152,000 | -15.6% | 86,734 | 0.0% | 0.01% | -12.5% |
Q4 2018 | $180,000 | -30.2% | 86,734 | 0.0% | 0.01% | -42.9% |
Q3 2018 | $258,000 | +3.6% | 86,734 | 0.0% | 0.01% | -33.3% |
Q2 2018 | $249,000 | -8.5% | 86,734 | 0.0% | 0.02% | -41.7% |
Q1 2018 | $272,000 | -3.9% | 86,734 | 0.0% | 0.04% | -10.0% |
Q4 2017 | $283,000 | – | 86,734 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 293,057 | $481,000 | 0.20% |
Eidelman Virant Capital | 113,000 | $185,000 | 0.07% |
Susquehanna International Group Ltd. | 31,753 | $55,000 | 0.02% |
ARK Investment Management | 3,611,842 | $6,020,000 | 0.02% |
Senvest Management, LLC | 230,606 | $378,000 | 0.01% |
Csenge Advisory Group | 28,700 | $96,000 | 0.01% |
MGO ONE SEVEN LLC | 25,340 | $42,000 | 0.00% |
OCCUDO QUANTITATIVE STRATEGIES LP | 25,826 | $42,000 | 0.00% |
SNS Financial Group, LLC | 10,000 | $16,000 | 0.00% |
Vident Investment Advisory, LLC | 49,786 | $82,000 | 0.00% |